Crispr Therapeutics shares owned by Farrow Financial
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Farrow Financial
from 13F filings
Historical chart of Farrow Financial investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Farrow Financial consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Farrow Financial
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.1M | 17k | 64.81 |
| 2025-06-30 | $837k | 17k | 48.64 |
| 2025-03-31 | $591k | 17k | 34.03 |
| 2024-12-31 | $777k | 20k | 38.65 |
| 2024-09-30 | $932k | 20k | 46.98 |
| 2024-06-30 | $938k | 17k | 54.01 |
| 2024-03-31 | $1.2M | 17k | 68.16 |
| 2023-12-31 | $1.2M | 19k | 62.60 |